ArticleJournal of clinical and experimental dentistry2025
Clinical-Pathological profile of head and neck cancers other than squamous cell carcinoma: A retrospective 20-year follow-up study.
Article in Journal of clinical and experimental dentistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Squamous cell carcinoma (SCC) of the head and neck is the main histological type and the sixth most common cancer in the world. However, tumors other than squamous cell carcinoma can affect the oral cavity, such as salivary gland carcinomas, lymphomas and sarcomas. Material and Methods: A quantitative, retrospective, observational and cross-sectional study, in which 395 medical records of patients diagnosed/treated with non-SCC head and neck tumors from 2000 to 2020 at the Haroldo Juaçaba Hospital/Ceará Cancer Institute (HHJ/ICC) were analyzed. The data was compared using Pearson's chi-square test or Fisher's exact test, Kaplan-Meier overall survival curves were constructed and the Mantel-Cox log-rank test was used. Results: Salivary gland tumors (1st = Adenoid Cystic Carcinoma), followed by sarcomas (1st = Kaposi's Sarcoma) and lymphoproliferative tumors (1st = Diffuse Large B-Cell Lymphoma). The majority of the sample were women, with a mean age of 56 and a low level of education. Median overall survival was (95%CI = 57.29-101.71) months, with no difference between the lesion groups ( Conclusions: The frequency of non-SCC head and neck tumors is very low. There is no difference between men and women, age is a determining factor in differentiating tumors and lymph node metastasis is the main predictor of survival. In addition, schooling is an important risk factor for mortality in these patients.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.